9.56 -0.40 (-4.02%)

New 52W Low today

66,723 XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Entrada Therapeutics Inc

The latest disclosure was made by Kory J. Wentworth in Entrada Therapeutics Inc where a trade of 1,784 Common Stock done at an average price of $10.7 was reported to US exchanges on March 17, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 10.67 per share. 17 Mar 2025 1,784 109,536 - 10.7 19,035 Common Stock
Dipal Doshi Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 116,200 441,953 - 0 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. 01 Mar 2025 17,566 424,387 - 11.7 205,146 Common Stock
Dipal Doshi Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 173,400 173,400 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 42,400 116,249 - 0 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. 01 Mar 2025 4,929 111,320 - 11.7 57,564 Common Stock
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 63,300 63,300 - - Stock Option (Right to Buy)
Nathan J. Dowden President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 60,800 185,949 - 0 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. 01 Mar 2025 5,144 180,805 - 11.7 60,075 Common Stock
Nathan J. Dowden President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 90,800 90,800 - - Stock Option (Right to Buy)
Natarajan Sethuraman President, Research & Develop. Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 60,800 205,797 - 0 Common Stock
Natarajan Sethuraman President, Research & Develop. Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.68 per share. 01 Mar 2025 6,138 199,659 - 11.7 71,683 Common Stock
Natarajan Sethuraman President, Research & Develop. Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2025 90,800 90,800 - - Stock Option (Right to Buy)
J. Kory Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Nov 2024 1,000 36,157 - - Stock Option (Right to Buy)
Wentworth Kory J. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 29 Nov 2024 5,000 78,849 - 2.1 10,500 Common Stock
Sethuraman Natarajan President, Research & Develop. Sale of securities on an exchange or to another person at price $ 20.15 per share. 29 Nov 2024 11,703 144,997 - 20.1 235,786 Common Stock
J. Kory Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Nov 2024 5,000 31,157 - - Stock Option (Right to Buy)
J. Kory Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 29 Nov 2024 1,000 74,849 - 2.1 2,100 Common Stock
Kory Wentworth J. Chief Financial Officer Sale of securities on an exchange or to another person at price $ 20.00 per share. 29 Nov 2024 5,000 73,849 - 20.0 99,978 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 20.26 per share. 29 Nov 2024 4,088 156,700 - 20.3 82,834 Common Stock
Sethuraman Natarajan President, Research & Develop. Sale of securities on an exchange or to another person at price $ 20.00 per share. 29 Nov 2024 100 160,788 - 20 2,000 Common Stock
Wentworth Kory J. Chief Financial Officer Sale of securities on an exchange or to another person at price $ 19.97 per share. 29 Nov 2024 1,000 73,849 - 20.0 19,970 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Nov 2024 6,000 37,157 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 11 Nov 2024 6,000 82,486 - 2.1 12,600 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 19.98 per share. 11 Nov 2024 8,637 73,849 - 20.0 172,562 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 20.04 per share. 11 Nov 2024 2,700 160,888 - 20.0 54,109 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 20.01 per share. 11 Nov 2024 1,409 163,588 - 20.0 28,191 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 18.02 per share. 04 Nov 2024 749 182,467 - 18.0 13,498 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 18.71 per share. 04 Nov 2024 9,554 167,742 - 18.7 178,752 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 19.32 per share. 04 Nov 2024 2,745 164,997 - 19.3 53,024 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 18.18 per share. 04 Nov 2024 5,171 177,296 - 18.2 94,006 Common Stock
Natarajan Sethuraman President, Research & Develop. Sale of securities on an exchange or to another person at price $ 18.00 per share. 16 Oct 2024 600 183,216 - 18 10,800 Common Stock
Nathan J. Dowden President & COO Sale of securities on an exchange or to another person at price $ 16.00 per share. 26 Sep 2024 847 125,149 - 16 13,552 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 14.97 per share. 09 Sep 2024 3,195 76,486 - 15.0 47,832 Common Stock
Nathan J. Dowden President & COO Sale of securities on an exchange or to another person at price $ 15.07 per share. 06 Sep 2024 1,904 125,996 - 15.1 28,690 Common Stock
Nathan J. Dowden President & COO Sale of securities on an exchange or to another person at price $ 15.20 per share. 06 Sep 2024 399 127,900 - 15.2 6,063 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 15.09 per share. 06 Sep 2024 2,642 183,816 - 15.1 39,862 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 15.24 per share. 06 Sep 2024 600 186,458 - 15.2 9,141 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. 03 Sep 2024 2,328 332,147 - 15.8 36,692 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. 03 Sep 2024 826 325,753 - 15.1 12,494 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. 03 Sep 2024 4,744 326,579 - 15.4 73,169 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. 03 Sep 2024 72 331,323 - 17.7 1,275 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. 03 Sep 2024 752 331,395 - 16.9 12,728 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. 03 Sep 2024 462 80,950 - 15.8 7,282 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. 03 Sep 2024 165 79,681 - 15.1 2,496 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. 03 Sep 2024 941 79,846 - 15.4 14,513 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. 03 Sep 2024 14 80,787 - 17.7 248 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. 03 Sep 2024 149 80,801 - 16.9 2,522 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.92 per share. 03 Sep 2024 156 129,468 - 16.9 2,640 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. 03 Sep 2024 171 128,299 - 15.1 2,587 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. 03 Sep 2024 983 128,470 - 15.4 15,161 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.73 per share. 03 Sep 2024 15 129,453 - 17.7 266 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. 03 Sep 2024 483 129,624 - 15.8 7,613 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.76 per share. 03 Sep 2024 469 188,345 - 15.8 7,392 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.13 per share. 03 Sep 2024 167 187,058 - 15.1 2,526 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.42 per share. 03 Sep 2024 955 187,225 - 15.4 14,729 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.71 per share. 03 Sep 2024 14 188,180 - 17.7 248 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.93 per share. 03 Sep 2024 151 188,194 - 16.9 2,556 Common Stock
Nathan J. Dowden President & COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. 16 Aug 2024 20,000 157,204 - 1.7 34,800 Common Stock
Nathan J. Dowden President & COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Aug 2024 20,000 64,831 - - Stock Option (Right to Buy)
Nathan J. Dowden President & COO Sale of securities on an exchange or to another person at price $ 16.70 per share. 16 Aug 2024 502 130,107 - 16.7 8,382 Common Stock
Nathan J. Dowden President & COO Sale of securities on an exchange or to another person at price $ 16.26 per share. 16 Aug 2024 26,595 130,609 - 16.3 432,419 Common Stock
Dipal Doshi Director, CEO Sale of securities on an exchange or to another person at price $ 17.81 per share. 12 Jul 2024 1,600 334,475 - 17.8 28,497 Common Stock
Dipal Doshi Director, CEO Sale of securities on an exchange or to another person at price $ 18.00 per share. 12 Jul 2024 300 336,075 - 18 5,400 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 18.00 per share. 12 Jul 2024 638 188,814 - 18 11,484 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 18.00 per share. 12 Jul 2024 600 189,452 - 18 10,800 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 14.95 per share. 08 Jul 2024 1,758 81,412 - 14.9 26,282 Common Stock
Peter S. Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (Right to Buy)
Dipal Doshi Director, CEO Sale of securities on an exchange or to another person at price $ 16.17 per share. 13 Jun 2024 1,000 336,375 - 16.2 16,174 Common Stock
Mary T. Thistle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (Right to Buy)
Kush M. Parmar Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (Right to Buy)
Bernhardt G. Zeiher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (Right to Buy)
Gina Chapman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 16,000 16,000 - - Stock Option (Right to Buy)
Peter S. Kim Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jun 2024 11,918 0 - - Stock Option (Right to Buy)
Peter S. Kim Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.06 per share. 03 Jun 2024 11,918 104,330 - 6.1 72,223 Common Stock
Dipal Doshi Director, CEO Sale of securities on an exchange or to another person at price $ 15.00 per share. 16 May 2024 1,800 338,575 - 15 27,000 Common Stock
Dipal Doshi Director, CEO Sale of securities on an exchange or to another person at price $ 15.11 per share. 16 May 2024 1,200 337,375 - 15.1 18,129 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 15.19 per share. 16 May 2024 9,675 190,052 - 15.2 146,944 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 15.00 per share. 16 May 2024 1,000 208,032 - 15 15,000 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 15.14 per share. 16 May 2024 8,305 199,727 - 15.1 125,751 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 14.59 per share. 14 May 2024 25,000 92,412 - 14.6 364,673 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 14.25 per share. 08 May 2024 2,200 67,412 - 14.2 31,341 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 14.04 per share. 08 May 2024 2,276 65,212 - 14.0 31,965 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 13.57 per share. 08 Apr 2024 2,600 62,936 - 13.6 35,290 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 13.75 per share. 28 Mar 2024 1,512 60,336 - 13.8 20,794 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 13.64 per share. 22 Mar 2024 2,750 58,824 - 13.6 37,509 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 13.36 per share. 22 Mar 2024 3,180 56,074 - 13.4 42,472 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 13.76 per share. 22 Mar 2024 3,118 52,894 - 13.8 42,901 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 12.66 per share. 19 Mar 2024 900 47,944 - 12.7 11,397 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 13.24 per share. 19 Mar 2024 704 49,776 - 13.2 9,318 Common Stock
Peter S. Kim Director Purchase of securities on an exchange or from another person at price $ 12.66 per share. 19 Mar 2024 1,128 49,072 - 12.7 14,281 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Mar 2024 9,000 43,157 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 15 Mar 2024 9,000 83,170 - 2.1 18,900 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 12.31 per share. 06 Mar 2024 4,086 74,170 - 12.3 50,285 Common Stock
Nathan J. Dowden President & COO Sale of securities on an exchange or to another person at price $ 12.32 per share. 06 Mar 2024 1,826 137,204 - 12.3 22,499 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 01 Mar 2024 5,049 340,375 - 12.3 61,996 Common Stock
Dipal Doshi Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 158,500 158,500 - - Stock Option (Right to Buy)
Dipal Doshi Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 104,700 347,979 - 0 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. 01 Mar 2024 1,164 346,815 - 12.4 14,460 Common Stock
Dipal Doshi Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. 01 Mar 2024 1,391 345,424 - 13.4 18,594 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 01 Mar 2024 1,471 78,256 - 12.3 18,062 Common Stock
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 46,800 46,800 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 30,900 80,471 - 0 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. 01 Mar 2024 339 80,132 - 12.4 4,211 Common Stock
Kory J. Wentworth Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. 01 Mar 2024 405 79,727 - 13.4 5,414 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. 01 Mar 2024 343 140,925 - 12.4 4,261 Common Stock
Nathan J. Dowden President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 60,000 141,268 - 0 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 01 Mar 2024 1,486 139,030 - 12.3 18,246 Common Stock
Nathan J. Dowden President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 50,100 50,100 - - Stock Option (Right to Buy)
Nathan J. Dowden President & COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 33,100 81,268 - 0 Common Stock
Nathan J. Dowden President & COO Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. 01 Mar 2024 409 140,516 - 13.4 5,467 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.28 per share. 01 Mar 2024 1,505 209,032 - 12.3 18,480 Common Stock
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 44,100 211,298 - 0 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.42 per share. 01 Mar 2024 347 210,951 - 12.4 4,311 Common Stock
Natarajan Sethuraman Chief Scientific Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.37 per share. 01 Mar 2024 414 210,537 - 13.4 5,534 Common Stock
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 66,800 66,800 - - Stock Option (Right to Buy)
Dipal Doshi Director, CEO Sale of securities on an exchange or to another person at price $ 15.00 per share. 15 Feb 2024 1,000 243,279 - 15 15,000 Common Stock
Dipal Doshi Director, CEO Sale of securities on an exchange or to another person at price $ 15.99 per share. 16 Jan 2024 1,000 244,279 - 16.0 15,990 Common Stock
Kory Wentworth J. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 21 Dec 2023 10,206 59,777 - 2.1 21,433 Common Stock
Wentworth J. Kory Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2023 94 52,157 - - Stock Option (Right to Buy)
Kory Wentworth J. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2023 10,206 52,251 - - Stock Option (Right to Buy)
Wentworth Kory J. Chief Financial Officer Sale of securities on an exchange or to another person at price $ 16.48 per share. 21 Dec 2023 3,677 49,571 - 16.5 60,611 Common Stock
Kory Wentworth J. Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2023 2,200 62,457 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 21 Dec 2023 2,200 51,771 - 2.1 4,620 Common Stock
J. Kory Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 15.24 per share. 21 Dec 2023 6,529 53,248 - 15.2 99,513 Common Stock
J. Wentworth Kory Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 21 Dec 2023 94 49,665 - 2.1 197 Common Stock
Wentworth Kory J. Chief Financial Officer Sale of securities on an exchange or to another person at price $ 16.67 per share. 21 Dec 2023 94 49,571 - 16.7 1,567 Common Stock
Wentworth J. Kory Chief Financial Officer Sale of securities on an exchange or to another person at price $ 15.07 per share. 21 Dec 2023 2,200 49,571 - 15.1 33,155 Common Stock
Doshi Dipal Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.00 per share. 20 Dec 2023 1,000 245,279 - 15 15,000 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 16.23 per share. 13 Nov 2023 1,000 246,279 - 16.2 16,230 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.67 per share. 14 Aug 2023 1,000 201,069 - 15.7 15,671 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2023 6,898 88,012 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2023 9,464 94,910 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Aug 2023 10,348 104,374 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.14 per share. 02 Aug 2023 6,898 27,130 - 14.1 97,521 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 02 Aug 2023 6,898 34,028 - 2.1 14,486 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 14.74 per share. 02 Aug 2023 9,464 27,130 - 14.7 139,530 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 02 Aug 2023 9,464 36,594 - 2.1 19,874 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 16.82 per share. 02 Aug 2023 68 27,130 - 16.8 1,144 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 16.01 per share. 02 Aug 2023 1,000 27,198 - 16.0 16,012 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 02 Aug 2023 10,348 37,478 - 2.1 21,731 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.09 per share. 02 Aug 2023 9,280 28,198 - 15.1 140,013 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 17.98 per share. 10 Jul 2023 6,116 36,747 - 18.0 109,958 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2023 3,884 64,657 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Jul 2023 6,116 68,541 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.00 per share. 10 Jul 2023 3,884 36,747 - 18.0 69,904 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 10 Jul 2023 3,884 40,631 - 2.1 8,156 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 10 Jul 2023 6,116 42,863 - 2.1 12,844 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 18.05 per share. 10 Jul 2023 3,897 35,376 - 18.0 70,333 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 18.00 per share. 10 Jul 2023 3,200 39,273 - 18.0 57,605 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 18.04 per share. 10 Jul 2023 14,852 153,447 - 18.0 267,915 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 18.00 per share. 10 Jul 2023 3,026 168,299 - 18.0 54,474 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jun 2023 8,790 74,657 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 29 Jun 2023 8,790 36,747 - 2.1 18,459 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 14.84 per share. 21 Jun 2023 8,593 36,864 - 14.8 127,519 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 21 Jun 2023 17,500 45,457 - 2.1 36,750 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 15.17 per share. 21 Jun 2023 8,907 27,957 - 15.2 135,129 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Jun 2023 17,500 83,447 - - Stock Option (Right to Buy)
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 16.02 per share. 20 Jun 2023 7,097 42,473 - 16.0 113,700 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 14.94 per share. 20 Jun 2023 8,885 49,570 - 14.9 132,704 Common Stock
John F. Crowley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 16,000 16,000 - - Stock Option (Right to Buy)
Peter S. Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 16,000 16,000 - - Stock Option (Right to Buy)
Mary T. Thistle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 16,000 16,000 - - Stock Option (Right to Buy)
Kush M. Parmar Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 16,000 16,000 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.71 per share. 27 Apr 2023 2,000 202,069 - 13.7 27,422 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 18.01 per share. 17 Apr 2023 2,092 204,069 - 18.0 37,675 Common Stock
Natarajan Sethuraman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 18.00 per share. 17 Apr 2023 3,961 171,325 - 18.0 71,316 Common Stock
Bernhardt G. Zeiher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Apr 2023 32,000 32,000 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 14.63 per share. 27 Mar 2023 1,800 256,011 - 14.6 26,333 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.51 per share. 27 Mar 2023 200 255,811 - 15.5 3,102 Common Stock
Dipal Doshi Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 75,250 75,250 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 49,650 206,161 - 0 Common Stock
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 14,200 27,957 - 0 Common Stock
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 21,500 21,500 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 21,500 21,500 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 14,200 27,130 - 0 Common Stock
Nathan J. Dowden Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 21,500 21,500 - - Stock Option (Right to Buy)
Nathan J. Dowden Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 14,200 58,455 - 0 Common Stock
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 14,200 175,286 - 0 Common Stock
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2023 21,500 21,500 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.00 per share. 28 Feb 2023 2,000 161,835 - 12 24,000 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.00 per share. 27 Jan 2023 2,000 163,835 - 12.0 24,001 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.02 per share. 09 Jan 2023 2,410 165,835 - 15.0 36,196 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 13.45 per share. 30 Dec 2022 5,200 15,516 - 13.4 69,932 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 14.80 per share. 27 Dec 2022 600 182,235 - 14.8 8,879 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.01 per share. 27 Dec 2022 400 168,245 - 15.0 6,005 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.01 per share. 27 Dec 2022 4,521 168,645 - 15.0 67,852 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.04 per share. 27 Dec 2022 9,069 173,166 - 15.0 136,383 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.95 per share. 08 Dec 2022 4,550 16,509 - 19.0 86,238 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Dec 2022 4,550 100,947 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 08 Dec 2022 4,550 21,059 - 2.1 9,555 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 02 Dec 2022 2,910 19,419 - 2.1 6,111 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Dec 2022 200 105,497 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Dec 2022 2,910 105,697 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.05 per share. 02 Dec 2022 200 16,509 - 18.1 3,610 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 02 Dec 2022 200 16,709 - 2.1 420 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.20 per share. 02 Dec 2022 2,910 16,509 - 18.2 52,949 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.91 per share. 28 Nov 2022 2,000 182,835 - 13.9 27,826 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 16 Nov 2022 200 16,709 - 2.1 420 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Nov 2022 200 108,607 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.10 per share. 16 Nov 2022 200 16,509 - 18.1 3,620 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 24.05 per share. 31 Oct 2022 2,100 45,283 - 24.0 50,495 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 20.76 per share. 25 Oct 2022 7,506 188,335 - 20.8 155,808 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 21.66 per share. 25 Oct 2022 2,000 184,835 - 21.7 43,325 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 21.50 per share. 25 Oct 2022 1,500 186,835 - 21.5 32,251 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 20.01 per share. 25 Oct 2022 3,055 195,841 - 20.0 61,127 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 21.21 per share. 25 Oct 2022 643 25,033 - 21.2 13,638 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 25 Oct 2022 4,960 25,676 - 2.1 10,416 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 22.13 per share. 25 Oct 2022 100 20,716 - 22.1 2,213 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 21.42 per share. 25 Oct 2022 2,998 20,816 - 21.4 64,215 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 20.53 per share. 25 Oct 2022 4,942 23,814 - 20.5 101,462 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 25 Oct 2022 8,040 28,756 - 2.1 16,884 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2022 4,960 114,722 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Oct 2022 8,040 119,682 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 22.01 per share. 25 Oct 2022 4,317 20,716 - 22.0 95,021 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 20.10 per share. 25 Oct 2022 3,034 53,697 - 20.1 60,996 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 21.85 per share. 25 Oct 2022 900 47,383 - 21.9 19,669 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 20.97 per share. 25 Oct 2022 5,414 48,283 - 21.0 113,526 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 18.01 per share. 20 Oct 2022 811 204,024 - 18.0 14,607 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 19.65 per share. 20 Oct 2022 1,241 198,896 - 19.6 24,380 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 18.90 per share. 20 Oct 2022 1,101 200,137 - 18.9 20,809 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 18.28 per share. 20 Oct 2022 2,786 201,238 - 18.3 50,917 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 18.29 per share. 20 Oct 2022 2,771 59,135 - 18.3 50,668 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 19.66 per share. 20 Oct 2022 1,302 56,731 - 19.7 25,595 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 18.88 per share. 20 Oct 2022 1,102 58,033 - 18.9 20,807 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 18.07 per share. 20 Oct 2022 905 61,906 - 18.1 16,357 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 16.30 per share. 26 Sep 2022 288 212,339 - 16.3 4,695 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.23 per share. 26 Sep 2022 3,085 204,835 - 15.2 46,997 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.82 per share. 26 Sep 2022 966 207,920 - 15.8 15,286 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.04 per share. 26 Sep 2022 3,453 208,886 - 15.0 51,934 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.22 per share. 26 Sep 2022 2,795 212,627 - 15.2 42,530 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.22 per share. 26 Sep 2022 2,768 21,016 - 15.2 42,131 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 16.33 per share. 26 Sep 2022 300 20,716 - 16.3 4,899 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 26 Sep 2022 3,068 23,784 - 2.1 6,443 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2022 3,122 16,032 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2022 2,403 19,154 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2022 3,068 21,557 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.25 per share. 26 Sep 2022 3,122 20,716 - 15.2 47,610 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 26 Sep 2022 3,122 23,838 - 2.1 6,556 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.31 per share. 26 Sep 2022 2,403 20,716 - 15.3 36,789 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 26 Sep 2022 2,403 23,119 - 2.1 5,046 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 16.25 per share. 26 Sep 2022 215 62,811 - 16.2 3,493 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 15.32 per share. 26 Sep 2022 1,329 63,026 - 15.3 20,360 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.07 per share. 21 Sep 2022 1,023 215,422 - 15.1 15,413 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.12 per share. 21 Sep 2022 3,402 216,445 - 15.1 51,425 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.08 per share. 21 Sep 2022 3,341 20,716 - 15.1 50,393 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Sep 2022 939 24,625 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Sep 2022 3,341 25,564 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.09 per share. 21 Sep 2022 939 20,716 - 15.1 14,167 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 21 Sep 2022 939 21,655 - 2.1 1,972 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 21 Sep 2022 3,341 24,057 - 2.1 7,016 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 15.13 per share. 21 Sep 2022 3,275 65,373 - 15.1 49,537 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 15.07 per share. 21 Sep 2022 1,018 64,355 - 15.1 15,341 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.04 per share. 15 Sep 2022 200 219,847 - 15.0 3,008 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2022 106 28,905 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 15 Sep 2022 106 20,822 - 2.1 223 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.01 per share. 15 Sep 2022 106 20,716 - 15.0 1,591 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 15.01 per share. 15 Sep 2022 100 68,648 - 15.0 1,501 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.16 per share. 08 Sep 2022 1,100 220,735 - 15.2 16,673 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 15.07 per share. 08 Sep 2022 688 220,047 - 15.1 10,366 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.07 per share. 08 Sep 2022 800 20,716 - 15.1 12,054 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 08 Sep 2022 800 21,516 - 2.1 1,680 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 08 Sep 2022 1,221 21,937 - 2.1 2,564 Common Stock
Nerissa C. Kreher Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.13 per share. 08 Sep 2022 1,221 20,716 - 15.1 18,478 Common Stock
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Sep 2022 800 29,011 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Sep 2022 1,221 29,811 - - Stock Option (Right to Buy)
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 15.06 per share. 08 Sep 2022 865 68,748 - 15.1 13,031 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 15.15 per share. 08 Sep 2022 912 69,613 - 15.1 13,814 Common Stock
Dipal Doshi Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 15,125 221,835 - 0 Common Stock
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 5,503 16,489 - 0 Common Stock
Nerissa C. Kreher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 5,172 20,716 - 0 Common Stock
Nathan J. Dowden Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 5,632 70,525 - 0 Common Stock
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2022 5,794 162,144 - 0 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 13.51 per share. 29 Aug 2022 505 207,096 - 13.5 6,822 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.00 per share. 29 Aug 2022 171 206,710 - 12 2,052 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.00 per share. 29 Aug 2022 190 206,881 - 12 2,280 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 14.00 per share. 29 Aug 2022 25 207,071 - 14 350 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.56 per share. 29 Aug 2022 1,109 207,601 - 12.6 13,931 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.52 per share. 24 Aug 2022 2,817 12,838 - 13.5 38,093 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Aug 2022 1,117 108,807 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 14.18 per share. 24 Aug 2022 1,551 10,986 - 14.2 21,986 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 14.23 per share. 24 Aug 2022 301 12,537 - 14.2 4,282 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 24 Aug 2022 1,117 15,655 - 2.1 2,346 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.08 per share. 19 Aug 2022 8,529 16,144 - 13.1 111,530 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Aug 2022 1,403 109,924 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Aug 2022 117 111,327 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Aug 2022 4,452 111,444 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.09 per share. 19 Aug 2022 2,909 14,538 - 13.1 38,080 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 19 Aug 2022 1,403 17,447 - 2.1 2,946 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.00 per share. 19 Aug 2022 217 16,044 - 13.0 2,822 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 19 Aug 2022 117 16,261 - 2.1 246 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 19 Aug 2022 4,452 24,673 - 2.1 9,349 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Aug 2022 100 115,896 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Aug 2022 100 115,996 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Aug 2022 100 116,096 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.00 per share. 16 Aug 2022 200 20,221 - 13 2,600 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 16 Aug 2022 100 20,441 - 2.1 210 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.07 per share. 16 Aug 2022 200 20,341 - 13.1 2,614 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 16 Aug 2022 100 20,541 - 2.1 210 Common Stock
Kory J. Wentworth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 13.00 per share. 16 Aug 2022 200 20,441 - 13 2,600 Common Stock
Kory J. Wentworth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 16 Aug 2022 100 20,641 - 2.1 210 Common Stock
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.00 per share. 27 Jul 2022 2,000 208,710 - 12 24,000 Common Stock
Dipal Doshi Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2022 90,750 90,750 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2022 33,019 33,019 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2022 31,032 31,032 - - Stock Option (Right to Buy)
Nathan J. Dowden Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2022 33,788 33,788 - - Stock Option (Right to Buy)
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2022 34,763 34,763 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Sale of securities on an exchange or to another person at price $ 12.00 per share. 27 Jun 2022 4,000 210,710 - 12 48,000 Common Stock
Nathan J. Dowden Chief Operating Officer Sale of securities on an exchange or to another person at price $ 13.00 per share. 27 Jun 2022 7,714 64,893 - 13 100,282 Common Stock
John F. Crowley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,918 11,918 - - Stock Option (Right to Buy)
Peter S. Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,918 11,918 - - Stock Option (Right to Buy)
Todd A. Foley Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,918 11,918 - - Stock Option (Right to Buy)
Mary T. Thistle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,918 11,918 - - Stock Option (Right to Buy)
Carole L. Nuechterlein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,918 11,918 - - Stock Option (Right to Buy)
Kush M. Parmar Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2022 11,918 11,918 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 181,500 181,500 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 30,250 214,710 - 0 Common Stock
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 66,038 66,038 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 11,006 20,541 - 0 Common Stock
Nerissa C. Kreher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 10,344 15,544 - 0 Common Stock
Nerissa C. Kreher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 62,063 62,063 - - Stock Option (Right to Buy)
Nathan J. Dowden Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 11,263 72,607 - 0 Common Stock
Nathan J. Dowden Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 67,575 67,575 - - Stock Option (Right to Buy)
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 11,588 156,350 - 0 Common Stock
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2022 69,525 69,525 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. 13 Jan 2022 10,000 184,460 - 1.7 17,400 Common Stock
Dipal Doshi Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Jan 2022 10,000 399,989 - - Stock Option (Right to Buy)
John F. Crowley Director Purchase of securities on an exchange or from another person at price $ 9.72 per share. 12 Jan 2022 5,000 5,000 - 9.7 48,575 Common Stock
Nerissa C. Kreher Chief Medical Officer 29 Dec 2021 5,200 142,722 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 29 Dec 2021 5,200 5,200 - 2.1 10,920 Common Stock
Todd A. Foley Director, Ten Percent Owner 02 Nov 2021 3,816,760 3,816,760 - - Common Stock
Todd A. Foley Director, Ten Percent Owner 02 Nov 2021 3,683,241 0 - - Series B Preferred Stock
Todd A. Foley Director, Ten Percent Owner 02 Nov 2021 27,617,675 0 - - Series A Preferred Stock
Todd A. Foley Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 02 Nov 2021 100,000 4,425,784 - 20 2,000,000 Common Stock
Todd A. Foley Director, Ten Percent Owner 02 Nov 2021 509,024 4,325,784 - - Common Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 564,217 564,217 - - Common Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 318,140 882,357 - - Common Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 254,512 3,276,022 - - Common Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 2,371,739 3,021,510 - - Common Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 318,140 0 - - Series B Preferred Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 254,512 0 - - Series B Preferred Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 318,616 649,771 - - Common Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 564,217 0 - - Series A Preferred Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 2,371,739 0 - - Series A Preferred Stock
Kush M. Parmar Director, Ten Percent Owner 02 Nov 2021 318,616 0 - - Series Seed Preferred Stock
Kush M. Parmar Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 20.00 per share. 02 Nov 2021 250,000 1,132,357 - 20 5,000,000 Common Stock
John F. Crowley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 11,918 11,918 - - Stock Option (Right to Buy)
Peter S. Kim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 11,918 11,918 - - Stock Option (Right to Buy)
Todd A. Foley Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 23,552 23,552 - - Stock Option (Right to Buy)
Dipal Doshi Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 184,821 184,821 - - Stock Option (Right to Buy)
Mary T. Thistle Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 11,918 11,918 - - Stock Option (Right to Buy)
Carole L. Nuechterlein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 23,552 23,522 - - Stock Option (Right to Buy)
Kush M. Parmar Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 23,552 23,552 - - Stock Option (Right to Buy)
Kory J. Wentworth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 72,012 72,012 - - Stock Option (Right to Buy)
Nerissa C. Kreher Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 72,012 72,012 - - Stock Option (Right to Buy)
Nathan J. Dowden Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 95,148 95,148 - - Stock Option (Right to Buy)
Natarajan Sethuraman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2021 243,639 243,639 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures